Medicare Drug Planners Now Lobbyists, With Billions at StakeQuicklink submitted by Margaret Bassett Permalink
Become a Fan
|Six years ago, a group of lawmakers and aides crafted Medicare Part D, the prescription drug program for seniors that has produced billions of dollars of profits for pharmaceutical companies. Today, at least 25 of those key players are back, but this time they're lobbyists, trying to persuade their former colleagues to protect the lucrative system during the health care reform negotiations.|
The time limit for entering new comments on this Quicklink has expired.
This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.